Tag: research

Star Therapeutics
Global, United States

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced the appointment of Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer. Mr. Robertson brings more than twenty years of experience with corporate strategy, business operations, capital raising and M&A. “I’m very excited to join the Star Therapeutics team at a time of great momentum … Continue reading Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

Impact Newswire
1910 GENETICS
Global, United States

1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Dr. Gandhi is VP and Head of Strategic Partnerships for Pfizer Ignite and will bring clinical, strategic and financial leadership to biotech’s board BOSTON–(BUSINESS WIRE)–1910 Genetics, the only biotech advancing small and large molecule drug discovery with an automated, multimodal AI platform, today announced the appointment of Shaan C. Gandhi, MD, DPhil, to its board of directors. Gandhi joins as an independent board director and … Continue reading 1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Impact Newswire
ArrivoBio
Global, United States

ArrivoBio Raises $45M in Series B Financing to Advance Pipeline

Funds will advance two novel drug candidates, SP-624 for major depressive disorder moving into late-stage development, and RABI-767 for the treatment of severe acute pancreatitis entering Phase 2 SP-624 is a first-in-class treatment activating SIRT6 for the treatment of major depression and other neuropsychiatric disorders MORRISVILLE, N.C.–(BUSINESS WIRE)–Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $45.25 million in committed … Continue reading ArrivoBio Raises $45M in Series B Financing to Advance Pipeline

Impact Newswire
CNA
Global, United States

MARYANN SURRICK NAMED AS GENERAL COUNSEL AT CNA

Monday, October 9, 2023 – Arlington, VA CNA welcomes Maryann Surrick to CNA as its new general counsel and senior vice president. Surrick is a top-tier government contracts attorney with experience working for both a nonprofit organization and a Fortune 50 corporation. Most recently, Surrick served as general counsel for The Sentry, an international human rights NGO. She previously was an executive-level in-house lawyer at … Continue reading MARYANN SURRICK NAMED AS GENERAL COUNSEL AT CNA

Impact Newswire
Tevogen Bio
Global, United States

Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative

October 23, 2023 04:35 PM Eastern Daylight Time WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio Inc. (“Tevogen Bio”) today announced the appointment of Mittul Mehta as Chief Information Officer (CIO) and Head of Tevogen.ai, the newly launched initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. “I am excited to join Tevogen Bio at such a … Continue reading Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative

Impact Newswire
VILYA
Global, United States

Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

Company adds to Board of Directors and forms Scientific Advisory Board October 17, 2023 08:00 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines thatprecisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer. “I am very excited to join the phenomenal team at Vilya developing new macrocycle drugs” “I … Continue reading Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

Impact Newswire
LIMMATECH BIOLOGICS AG
Europe

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

October 09, 2023 04:00 AM Eastern Daylight Time SCHLIEREN, Switzerland – LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against … Continue reading LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

Impact Newswire
Angel Reyes
Global

Angel Reyes Joins Altasciences as General Manager of CDMO Services

October 06, 2023 10:00 AM Eastern Daylight Time LAVAL, Québec – Altasciences is pleased to welcome Angel Reyes as General Manager, Contract Development and Manufacturing Organization (CDMO) Services.“Angel’s scientific knowledge and wealth of experience gained over years in managing manufacturing operations, combined with his ability to find innovative solutions and improve day-to-day operations, makes him a valuable addition to the CDMO team. I am confident he … Continue reading Angel Reyes Joins Altasciences as General Manager of CDMO Services

Impact Newswire
Odyssey Therapeutics
United States

Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer

October 04, 2023 08:00 AM Eastern Daylight Time BOSTON – Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision immunomodulators and oncology medicines, today announced the appointment of Jeremy Sokolove, M.D., as chief medical officer. In this role, Dr. Sokolove will develop, lead and drive the development strategy and execution of all Odyssey’s clinical assets. Additionally, he will be responsible for selecting, prioritizing and accelerating … Continue reading Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer

Impact Newswire